Age control of the first appearance datum for Javanese Homo erectus in the Sangiran area.

The chronology of the World Heritage Site of Sangiran in Indonesia is crucial for the understanding of human dispersals and settlement in Asia in the Early Pleistocene (before 780,000 years ago). It has been controversial, however, especially regarding the timing of the earliest hominin migration into the Sangiran region. We use a method of combining fission-track and uranium-lead dating and present key ages to calibrate the lower (older) Sangiran hominin-bearing horizons. We conclude that the first appearance datum for the Sangiran hominins is most likely ~1.3 million years ago and less than 1.5 million years ago, which is markedly later than the dates that have been widely accepted for the past two decades.

High-resolution record of the Matuyama-Brunhes transition constrains the age of Javanese Homo erectus in the Sangiran dome, Indonesia.

A detailed paleomagnetic study conducted in the Sangiran area, Java, has provided a reliable age constraint on hominid fossil-bearing formations. A reverse-to-normal polarity transition marks a 7-m thick section across the Upper Tuff in the Bapang Formation. The transition has three short reversal episodes and is overlain by a thick normal polarity magnetozone that was fission-track dated to the Brunhes chron. This pattern closely resembles another high-resolution Matuyama-Brunhes (MB) transition record in an Osaka Bay marine core. In the Sangiran sediments, four successive transitional polarity fields lie just below the presumed main MB boundary. Their virtual geomagnetic poles cluster in the western South Pacific, partly overlapping the transitional virtual geomagnetic poles from Hawaiian and Canary Islands' lavas, which have a mean (40)Ar/(39)Ar age of 776 ± 2 ka. Thus, the polarity transition is unambiguously the MB boundary. A revised correlation of tuff layers in the Bapang Formation reveals that the hominid last occurrence and the tektite level in the Sangiran area are nearly coincident, just below the Upper Middle Tuff, which underlies the MB transition. The stratigraphic relationship of the tektite level to the MB transition in the Sangiran area is consistent with deep-sea core data that show that the meteorite impact preceded the MB reversal by about 12 ka. The MB boundary currently defines the uppermost horizon yielding Homo erectus fossils in the Sangiran area.

Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.

The identification of a safe and reliable alternative for patients with non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema is a frequent problem for dermatologists and other practitioners. Cyclooxygenase-2 (COX-2) inhibitors have been reported to be safe for NSAID-intolerant patients from the US and Europe but not all of them have yet been approved for use in Japan. It was our objective to investigate the clinical manifestations of oral NSAID challenges in Japanese patients with histories of urticaria and/or angioedema after the intake of NSAIDs and to find safe alternative drugs, including COX-2 inhibitors and a basic anti-inflammatory drug. Twenty subjects suspected NSAID-induced urticaria/angioedema from histories were included in a double-blind or single-blind, placebo-controlled oral challenge protocol using NSAIDs. Skin prick tests using NSAIDs, which were dissolved in saline, were conducted. The mean age of the patients was 37.3 years; 14 patients were female. The results of other challenge tests showed that the most frequently intolerated drugs was loxoprofen (100%), followed by acetyl salicylic (94.4%), etodolac (53.3%), dicrofenac (50%), acetaminophen (38.5%), meloxicam (33%), and tiaramide (21.4%). Urticaria and angioedema were induced after aspirin intake in 83.3% and 22.2% of patients, respectively, whereas an asthmatic response was seen in 5.6%. Skin prick tests with NSAIDs were 100% negative. This study showed that among the NSAIDs that are available in Japan and that were investigated in this study, tiaramide, which does not inhibit COX, is the relatively safe alternative drug for Japanese patients with NSAID-induced urtiacaria and/or angioedema. Furthermore, meloxicam seems to be better tolerated than etodolac between two selective COX-2 inhibitors.